nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—ORM1—vertebral column—malignant glioma	0.0587	0.143	CbGeAlD
Disopyramide—CYP3A4—Temozolomide—malignant glioma	0.0324	1	CbGbCtD
Disopyramide—KCND2—brainstem—malignant glioma	0.0276	0.0673	CbGeAlD
Disopyramide—KCND2—telencephalon—malignant glioma	0.0245	0.0597	CbGeAlD
Disopyramide—KCND3—brainstem—malignant glioma	0.024	0.0586	CbGeAlD
Disopyramide—KCND3—telencephalon—malignant glioma	0.0213	0.052	CbGeAlD
Disopyramide—KCND2—medulla oblongata—malignant glioma	0.0192	0.0469	CbGeAlD
Disopyramide—KCND2—midbrain—malignant glioma	0.0176	0.0429	CbGeAlD
Disopyramide—KCND2—spinal cord—malignant glioma	0.0171	0.0418	CbGeAlD
Disopyramide—KCND3—midbrain—malignant glioma	0.0153	0.0374	CbGeAlD
Disopyramide—KCND2—central nervous system—malignant glioma	0.0139	0.0339	CbGeAlD
Disopyramide—KCND2—cerebellum—malignant glioma	0.0136	0.0332	CbGeAlD
Disopyramide—KCND3—central nervous system—malignant glioma	0.0121	0.0296	CbGeAlD
Disopyramide—KCND3—cerebellum—malignant glioma	0.0118	0.0289	CbGeAlD
Disopyramide—KCND2—brain—malignant glioma	0.011	0.0269	CbGeAlD
Disopyramide—CHRM2—telencephalon—malignant glioma	0.0109	0.0266	CbGeAlD
Disopyramide—SLC22A1—telencephalon—malignant glioma	0.0107	0.0261	CbGeAlD
Disopyramide—CHRM1—telencephalon—malignant glioma	0.00992	0.0242	CbGeAlD
Disopyramide—KCND3—brain—malignant glioma	0.00962	0.0235	CbGeAlD
Disopyramide—CHRM3—telencephalon—malignant glioma	0.00888	0.0217	CbGeAlD
Disopyramide—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00834	0.0308	CcSEcCtD
Disopyramide—ORM1—spinal cord—malignant glioma	0.00819	0.02	CbGeAlD
Disopyramide—Coma—Carmustine—malignant glioma	0.00746	0.0276	CcSEcCtD
Disopyramide—Gynaecomastia—Carmustine—malignant glioma	0.00731	0.027	CcSEcCtD
Disopyramide—Dry eye—Temozolomide—malignant glioma	0.00729	0.0269	CcSEcCtD
Disopyramide—SCN5A—central nervous system—malignant glioma	0.00728	0.0178	CbGeAlD
Disopyramide—ORM1—central nervous system—malignant glioma	0.00664	0.0162	CbGeAlD
Disopyramide—CHRM2—central nervous system—malignant glioma	0.00619	0.0151	CbGeAlD
Disopyramide—SLC22A1—central nervous system—malignant glioma	0.00608	0.0149	CbGeAlD
Disopyramide—Diplopia—Carmustine—malignant glioma	0.00593	0.0219	CcSEcCtD
Disopyramide—SCN5A—brain—malignant glioma	0.00578	0.0141	CbGeAlD
Disopyramide—Diplopia—Temozolomide—malignant glioma	0.00573	0.0212	CcSEcCtD
Disopyramide—CHRM1—central nervous system—malignant glioma	0.00564	0.0138	CbGeAlD
Disopyramide—Hypokalaemia—Carmustine—malignant glioma	0.00539	0.0199	CcSEcCtD
Disopyramide—Muscular weakness—Carmustine—malignant glioma	0.00523	0.0193	CcSEcCtD
Disopyramide—Hypokalaemia—Temozolomide—malignant glioma	0.00521	0.0193	CcSEcCtD
Disopyramide—Muscular weakness—Temozolomide—malignant glioma	0.00505	0.0187	CcSEcCtD
Disopyramide—CHRM3—central nervous system—malignant glioma	0.00505	0.0123	CbGeAlD
Disopyramide—Abdominal distension—Temozolomide—malignant glioma	0.00498	0.0184	CcSEcCtD
Disopyramide—CHRM2—brain—malignant glioma	0.00492	0.012	CbGeAlD
Disopyramide—SLC22A1—brain—malignant glioma	0.00483	0.0118	CbGeAlD
Disopyramide—Sweating increased—Temozolomide—malignant glioma	0.00482	0.0178	CcSEcCtD
Disopyramide—Neutropenia—Carmustine—malignant glioma	0.00479	0.0177	CcSEcCtD
Disopyramide—Dysuria—Temozolomide—malignant glioma	0.00463	0.0171	CcSEcCtD
Disopyramide—Neutropenia—Temozolomide—malignant glioma	0.00463	0.0171	CcSEcCtD
Disopyramide—Pollakiuria—Temozolomide—malignant glioma	0.00457	0.0169	CcSEcCtD
Disopyramide—Erectile dysfunction—Temozolomide—malignant glioma	0.00456	0.0169	CcSEcCtD
Disopyramide—Depression—Carmustine—malignant glioma	0.00455	0.0168	CcSEcCtD
Disopyramide—Weight increased—Temozolomide—malignant glioma	0.00451	0.0167	CcSEcCtD
Disopyramide—CHRM1—brain—malignant glioma	0.00448	0.0109	CbGeAlD
Disopyramide—Depression—Temozolomide—malignant glioma	0.0044	0.0163	CcSEcCtD
Disopyramide—Hypoaesthesia—Carmustine—malignant glioma	0.00408	0.0151	CcSEcCtD
Disopyramide—CHRM3—brain—malignant glioma	0.00401	0.00978	CbGeAlD
Disopyramide—Hepatitis—Temozolomide—malignant glioma	0.00396	0.0146	CcSEcCtD
Disopyramide—Hypoaesthesia—Temozolomide—malignant glioma	0.00394	0.0146	CcSEcCtD
Disopyramide—Arrhythmia—Carmustine—malignant glioma	0.00366	0.0135	CcSEcCtD
Disopyramide—Dysgeusia—Temozolomide—malignant glioma	0.00338	0.0125	CcSEcCtD
Disopyramide—Vision blurred—Carmustine—malignant glioma	0.00336	0.0124	CcSEcCtD
Disopyramide—Vision blurred—Temozolomide—malignant glioma	0.00325	0.012	CcSEcCtD
Disopyramide—Ill-defined disorder—Temozolomide—malignant glioma	0.0032	0.0118	CcSEcCtD
Disopyramide—Angioedema—Temozolomide—malignant glioma	0.00315	0.0117	CcSEcCtD
Disopyramide—Malaise—Temozolomide—malignant glioma	0.00311	0.0115	CcSEcCtD
Disopyramide—Vertigo—Temozolomide—malignant glioma	0.0031	0.0115	CcSEcCtD
Disopyramide—Chest pain—Carmustine—malignant glioma	0.00304	0.0112	CcSEcCtD
Disopyramide—Confusional state—Carmustine—malignant glioma	0.00294	0.0109	CcSEcCtD
Disopyramide—Oedema—Carmustine—malignant glioma	0.00291	0.0108	CcSEcCtD
Disopyramide—Discomfort—Temozolomide—malignant glioma	0.0029	0.0107	CcSEcCtD
Disopyramide—Dry mouth—Temozolomide—malignant glioma	0.00287	0.0106	CcSEcCtD
Disopyramide—Thrombocytopenia—Carmustine—malignant glioma	0.00285	0.0105	CcSEcCtD
Disopyramide—Confusional state—Temozolomide—malignant glioma	0.00284	0.0105	CcSEcCtD
Disopyramide—Oedema—Temozolomide—malignant glioma	0.00282	0.0104	CcSEcCtD
Disopyramide—Anorexia—Carmustine—malignant glioma	0.00278	0.0103	CcSEcCtD
Disopyramide—CYP3A4—central nervous system—malignant glioma	0.00277	0.00677	CbGeAlD
Disopyramide—Thrombocytopenia—Temozolomide—malignant glioma	0.00276	0.0102	CcSEcCtD
Disopyramide—Skin disorder—Temozolomide—malignant glioma	0.00273	0.0101	CcSEcCtD
Disopyramide—Hypotension—Carmustine—malignant glioma	0.00272	0.0101	CcSEcCtD
Disopyramide—Hyperhidrosis—Temozolomide—malignant glioma	0.00272	0.0101	CcSEcCtD
Disopyramide—Anorexia—Temozolomide—malignant glioma	0.00268	0.00992	CcSEcCtD
Disopyramide—Insomnia—Carmustine—malignant glioma	0.00263	0.00974	CcSEcCtD
Disopyramide—Paraesthesia—Carmustine—malignant glioma	0.00262	0.00967	CcSEcCtD
Disopyramide—Dyspnoea—Carmustine—malignant glioma	0.0026	0.0096	CcSEcCtD
Disopyramide—Somnolence—Carmustine—malignant glioma	0.00259	0.00957	CcSEcCtD
Disopyramide—Insomnia—Temozolomide—malignant glioma	0.00255	0.00941	CcSEcCtD
Disopyramide—Decreased appetite—Carmustine—malignant glioma	0.00253	0.00936	CcSEcCtD
Disopyramide—Paraesthesia—Temozolomide—malignant glioma	0.00253	0.00935	CcSEcCtD
Disopyramide—Dyspnoea—Temozolomide—malignant glioma	0.00251	0.00928	CcSEcCtD
Disopyramide—Somnolence—Temozolomide—malignant glioma	0.0025	0.00925	CcSEcCtD
Disopyramide—Pain—Carmustine—malignant glioma	0.00249	0.00921	CcSEcCtD
Disopyramide—Constipation—Carmustine—malignant glioma	0.00249	0.00921	CcSEcCtD
Disopyramide—Dyspepsia—Temozolomide—malignant glioma	0.00248	0.00916	CcSEcCtD
Disopyramide—Decreased appetite—Temozolomide—malignant glioma	0.00245	0.00905	CcSEcCtD
Disopyramide—Fatigue—Temozolomide—malignant glioma	0.00243	0.00897	CcSEcCtD
Disopyramide—Constipation—Temozolomide—malignant glioma	0.00241	0.0089	CcSEcCtD
Disopyramide—Pain—Temozolomide—malignant glioma	0.00241	0.0089	CcSEcCtD
Disopyramide—Feeling abnormal—Carmustine—malignant glioma	0.0024	0.00887	CcSEcCtD
Disopyramide—Feeling abnormal—Temozolomide—malignant glioma	0.00232	0.00858	CcSEcCtD
Disopyramide—Body temperature increased—Carmustine—malignant glioma	0.0023	0.00851	CcSEcCtD
Disopyramide—Urticaria—Temozolomide—malignant glioma	0.00224	0.00827	CcSEcCtD
Disopyramide—Body temperature increased—Temozolomide—malignant glioma	0.00223	0.00823	CcSEcCtD
Disopyramide—Asthenia—Carmustine—malignant glioma	0.00209	0.00773	CcSEcCtD
Disopyramide—Asthenia—Temozolomide—malignant glioma	0.00202	0.00747	CcSEcCtD
Disopyramide—Diarrhoea—Carmustine—malignant glioma	0.00199	0.00737	CcSEcCtD
Disopyramide—Pruritus—Temozolomide—malignant glioma	0.00199	0.00736	CcSEcCtD
Disopyramide—Dizziness—Carmustine—malignant glioma	0.00193	0.00712	CcSEcCtD
Disopyramide—Diarrhoea—Temozolomide—malignant glioma	0.00193	0.00712	CcSEcCtD
Disopyramide—Dizziness—Temozolomide—malignant glioma	0.00186	0.00688	CcSEcCtD
Disopyramide—Vomiting—Carmustine—malignant glioma	0.00185	0.00685	CcSEcCtD
Disopyramide—Rash—Carmustine—malignant glioma	0.00184	0.00679	CcSEcCtD
Disopyramide—Dermatitis—Carmustine—malignant glioma	0.00184	0.00678	CcSEcCtD
Disopyramide—Headache—Carmustine—malignant glioma	0.00182	0.00675	CcSEcCtD
Disopyramide—Vomiting—Temozolomide—malignant glioma	0.00179	0.00662	CcSEcCtD
Disopyramide—Rash—Temozolomide—malignant glioma	0.00177	0.00656	CcSEcCtD
Disopyramide—Dermatitis—Temozolomide—malignant glioma	0.00177	0.00656	CcSEcCtD
Disopyramide—Headache—Temozolomide—malignant glioma	0.00176	0.00652	CcSEcCtD
Disopyramide—Nausea—Carmustine—malignant glioma	0.00173	0.0064	CcSEcCtD
Disopyramide—Nausea—Temozolomide—malignant glioma	0.00167	0.00618	CcSEcCtD
Disopyramide—Methadone—CYP2C18—malignant glioma	0.000844	0.574	CrCbGaD
Disopyramide—Methadone—CYP2B6—malignant glioma	0.000626	0.426	CrCbGaD
Disopyramide—CHRM3—Signaling by GPCR—F2—malignant glioma	8.99e-05	0.000314	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BDKRB2—malignant glioma	8.94e-05	0.000313	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GSTP1—malignant glioma	8.91e-05	0.000312	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—F2—malignant glioma	8.9e-05	0.000311	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—NCOR1—malignant glioma	8.86e-05	0.00031	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT2—malignant glioma	8.7e-05	0.000304	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT2—malignant glioma	8.67e-05	0.000303	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAT—malignant glioma	8.67e-05	0.000303	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CG—malignant glioma	8.63e-05	0.000302	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CG—malignant glioma	8.6e-05	0.000301	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT2—malignant glioma	8.58e-05	0.0003	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CG—malignant glioma	8.52e-05	0.000298	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PTPN11—malignant glioma	8.48e-05	0.000297	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PTPN11—malignant glioma	8.45e-05	0.000296	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH2—malignant glioma	8.42e-05	0.000295	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH2—malignant glioma	8.4e-05	0.000294	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PTPN11—malignant glioma	8.37e-05	0.000293	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CD—malignant glioma	8.35e-05	0.000292	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CD—malignant glioma	8.33e-05	0.000291	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH2—malignant glioma	8.31e-05	0.000291	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	8.25e-05	0.000288	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KNG1—malignant glioma	8.24e-05	0.000288	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KNG1—malignant glioma	8.22e-05	0.000287	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—NCOR1—malignant glioma	8.19e-05	0.000286	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KNG1—malignant glioma	8.14e-05	0.000285	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT2—malignant glioma	7.9e-05	0.000276	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT2—malignant glioma	7.87e-05	0.000275	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK1—malignant glioma	7.86e-05	0.000275	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK1—malignant glioma	7.83e-05	0.000274	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT2—malignant glioma	7.79e-05	0.000273	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK1—malignant glioma	7.75e-05	0.000271	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CAV1—malignant glioma	7.75e-05	0.000271	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—IDH2—malignant glioma	7.62e-05	0.000266	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CD—malignant glioma	7.59e-05	0.000265	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CD—malignant glioma	7.56e-05	0.000265	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	7.49e-05	0.000262	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP3—malignant glioma	7.3e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	7.28e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP3—malignant glioma	7.28e-05	0.000255	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CB—malignant glioma	7.26e-05	0.000254	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	7.24e-05	0.000253	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CAV1—malignant glioma	7.22e-05	0.000253	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDKN2B—malignant glioma	7.22e-05	0.000252	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP3—malignant glioma	7.21e-05	0.000252	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	7.19e-05	0.000251	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.16e-05	0.000251	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	7.15e-05	0.00025	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CG—malignant glioma	7.06e-05	0.000247	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTK2—malignant glioma	7.03e-05	0.000246	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTK2—malignant glioma	7.01e-05	0.000245	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	7e-05	0.000245	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	6.98e-05	0.000244	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTK2—malignant glioma	6.94e-05	0.000243	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	6.91e-05	0.000242	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HES1—malignant glioma	6.91e-05	0.000242	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HES1—malignant glioma	6.88e-05	0.000241	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NCOR1—malignant glioma	6.87e-05	0.00024	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NCOR1—malignant glioma	6.84e-05	0.000239	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HES1—malignant glioma	6.82e-05	0.000238	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PPARG—malignant glioma	6.81e-05	0.000238	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NCOR1—malignant glioma	6.78e-05	0.000237	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—RAF1—malignant glioma	6.77e-05	0.000237	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—RAF1—malignant glioma	6.75e-05	0.000236	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.69e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—RAF1—malignant glioma	6.69e-05	0.000234	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAV1—malignant glioma	6.67e-05	0.000233	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—IL2—malignant glioma	6.67e-05	0.000233	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.61e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—IL2—malignant glioma	6.6e-05	0.000231	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	6.59e-05	0.000231	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CG—malignant glioma	6.58e-05	0.00023	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	6.58e-05	0.00023	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	6.55e-05	0.000229	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—IDH1—malignant glioma	6.55e-05	0.000229	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	6.53e-05	0.000228	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	6.49e-05	0.000227	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SPP1—malignant glioma	6.38e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SPP1—malignant glioma	6.36e-05	0.000223	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	6.36e-05	0.000222	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PPARG—malignant glioma	6.35e-05	0.000222	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SPHK1—malignant glioma	6.34e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	6.33e-05	0.000222	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SPP1—malignant glioma	6.3e-05	0.00022	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	6.27e-05	0.000219	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.21e-05	0.000217	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CD—malignant glioma	6.21e-05	0.000217	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CG—malignant glioma	6.08e-05	0.000213	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL2—malignant glioma	6.07e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL2—malignant glioma	6.05e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TERT—malignant glioma	6.05e-05	0.000212	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TERT—malignant glioma	6.03e-05	0.000211	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL2—malignant glioma	6e-05	0.00021	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TERT—malignant glioma	5.97e-05	0.000209	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.91e-05	0.000207	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PDGFB—malignant glioma	5.89e-05	0.000206	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.88e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PPARG—malignant glioma	5.87e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGFR1—malignant glioma	5.86e-05	0.000205	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PDGFB—malignant glioma	5.83e-05	0.000204	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGFR1—malignant glioma	5.8e-05	0.000203	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.79e-05	0.000202	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CD—malignant glioma	5.78e-05	0.000202	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HIF1A—malignant glioma	5.77e-05	0.000202	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HIF1A—malignant glioma	5.71e-05	0.0002	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.6e-05	0.000196	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CAV1—malignant glioma	5.58e-05	0.000195	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—malignant glioma	5.53e-05	0.000194	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CAV1—malignant glioma	5.53e-05	0.000193	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—malignant glioma	5.52e-05	0.000193	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—malignant glioma	5.46e-05	0.000191	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CB—malignant glioma	5.41e-05	0.000189	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—malignant glioma	5.36e-05	0.000187	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CD—malignant glioma	5.34e-05	0.000187	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FN1—malignant glioma	5.33e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—F2—malignant glioma	5.33e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—F2—malignant glioma	5.31e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FN1—malignant glioma	5.31e-05	0.000186	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BAD—malignant glioma	5.26e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—F2—malignant glioma	5.26e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FN1—malignant glioma	5.26e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BAD—malignant glioma	5.25e-05	0.000184	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	5.21e-05	0.000182	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	5.2e-05	0.000182	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BAD—malignant glioma	5.2e-05	0.000182	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	5.15e-05	0.00018	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CD80—malignant glioma	5.11e-05	0.000179	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	5.1e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APC—malignant glioma	5.1e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CD80—malignant glioma	5.09e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	5.08e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APC—malignant glioma	5.08e-05	0.000178	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CD80—malignant glioma	5.04e-05	0.000176	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CB—malignant glioma	5.04e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGF—malignant glioma	5.04e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APC—malignant glioma	5.03e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	5.03e-05	0.000176	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTT1—malignant glioma	5.02e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGF—malignant glioma	5.02e-05	0.000176	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTPN11—malignant glioma	5.01e-05	0.000175	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—malignant glioma	5e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTPN11—malignant glioma	4.99e-05	0.000175	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGF—malignant glioma	4.97e-05	0.000174	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTPN11—malignant glioma	4.94e-05	0.000173	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.79e-05	0.000168	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BRAF—malignant glioma	4.78e-05	0.000167	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BRAF—malignant glioma	4.73e-05	0.000165	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS1—malignant glioma	4.71e-05	0.000165	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTEN—malignant glioma	4.67e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.66e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CB—malignant glioma	4.66e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT2—malignant glioma	4.65e-05	0.000163	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.64e-05	0.000162	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—EGFR—malignant glioma	4.63e-05	0.000162	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—malignant glioma	4.61e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT2—malignant glioma	4.6e-05	0.000161	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—EGFR—malignant glioma	4.59e-05	0.00016	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.48e-05	0.000157	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	4.47e-05	0.000156	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.44e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	4.43e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	4.42e-05	0.000155	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—KRAS—malignant glioma	4.39e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	4.38e-05	0.000153	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—malignant glioma	4.38e-05	0.000153	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—KRAS—malignant glioma	4.37e-05	0.000153	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTEN—malignant glioma	4.36e-05	0.000152	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—KRAS—malignant glioma	4.33e-05	0.000151	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.32e-05	0.000151	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGF2—malignant glioma	4.29e-05	0.00015	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGF2—malignant glioma	4.28e-05	0.00015	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGF2—malignant glioma	4.24e-05	0.000148	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	4.03e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTEN—malignant glioma	4.02e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	4.02e-05	0.000141	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MDM2—malignant glioma	4.02e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MDM2—malignant glioma	4e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RAF1—malignant glioma	4e-05	0.00014	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.99e-05	0.000139	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.98e-05	0.000139	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.96e-05	0.000139	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.96e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.95e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.95e-05	0.000138	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.91e-05	0.000137	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.91e-05	0.000137	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.89e-05	0.000136	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.86e-05	0.000135	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.75e-05	0.000131	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.74e-05	0.000131	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.71e-05	0.00013	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.63e-05	0.000127	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	3.62e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.59e-05	0.000126	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL2—malignant glioma	3.59e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—malignant glioma	3.58e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.58e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL2—malignant glioma	3.58e-05	0.000125	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.55e-05	0.000124	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL2—malignant glioma	3.54e-05	0.000124	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GSTP1—malignant glioma	3.48e-05	0.000122	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.4e-05	0.000119	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAT—malignant glioma	3.39e-05	0.000119	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—malignant glioma	3.38e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.38e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTEN—malignant glioma	3.37e-05	0.000118	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.35e-05	0.000117	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.33e-05	0.000117	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PIK3CA—malignant glioma	3.3e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.29e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—malignant glioma	3.28e-05	0.000115	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.25e-05	0.000114	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NCOR1—malignant glioma	3.2e-05	0.000112	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PIK3CA—malignant glioma	3.07e-05	0.000107	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.05e-05	0.000107	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—malignant glioma	3.04e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.02e-05	0.000106	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.01e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—STAT3—malignant glioma	3.01e-05	0.000105	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.98e-05	0.000104	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PIK3CA—malignant glioma	2.84e-05	9.93e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MYC—malignant glioma	2.81e-05	9.81e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MYC—malignant glioma	2.8e-05	9.78e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MYC—malignant glioma	2.77e-05	9.69e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.74e-05	9.6e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.74e-05	9.57e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.71e-05	9.47e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—malignant glioma	2.69e-05	9.42e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAV1—malignant glioma	2.61e-05	9.12e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.59e-05	9.07e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.58e-05	9.04e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.56e-05	8.95e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—malignant glioma	2.51e-05	8.78e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.38e-05	8.33e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.38e-05	8.31e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	2.37e-05	8.3e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.35e-05	8.22e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—malignant glioma	2.32e-05	8.11e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TP53—malignant glioma	2.3e-05	8.06e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TP53—malignant glioma	2.3e-05	8.03e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPARG—malignant glioma	2.29e-05	8.02e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TP53—malignant glioma	2.27e-05	7.95e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.09e-05	7.31e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.95e-05	6.8e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.94e-05	6.78e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.92e-05	6.72e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.82e-05	6.37e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—malignant glioma	1.8e-05	6.31e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTEN—malignant glioma	1.57e-05	5.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.11e-05	3.88e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—malignant glioma	9.07e-06	3.17e-05	CbGpPWpGaD
